← Eichor
Study identifier: NCT06269198 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Postoperative Complications in Cancer Patients Monitored With Intelligent Continuous Monitoring System

Condition: Postoperative Complications · Cancer, Treatment-Related  ·  Sponsor: Rigshospitalet, Denmark

PhaseNA
Planned participants504
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective of this study is to determine the effect on complication severity of using a clinical monitoring system with automatic vital sign alerts in addition to routine monitoring versus routine monitoring alone in high-risk postoperative cancer patients within 30 days after surgery. Other objectives include documentation of the severity of complications within seven days of surgery, frequency of serious adverse events, mortality, length of stay and delay of planned chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Jesper Mølgaard, PhD  ·  +4535453545  ·  moelgaard.jesper@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Copenhagen University hospital - RigshospitaletCopenhagen, Other (Non US), DenmarkRecruiting
Bispebjerg HospitalCopenhagen, Other (Non US), DenmarkRecruiting
Hvidovre HospitalHvidovre, Other (Non US), DenmarkNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06269198